Single Cell Analysis Market Will Hit USD 6.98 Billion By 2027 at a CAGR of 17.2% – Reports and Data

September 22 19:01 2022
Single Cell Analysis Market Will Hit USD 6.98 Billion By 2027 at a CAGR of 17.2% - Reports and Data
Single Cell Analysis Market
The global Single Cell Analysis Market is forecasted to reach USD 6.98 Billion by 2027, according to a new report by Reports and Data

The global Single Cell Analysis Market is forecasted to reach USD 6.98 Billion by 2027, according to a new report by Reports and Data. The global Single-Cell Analysis market is forecasted to expand exponentially owing to the increasing biopharmaceutical and biotechnology industries. Furthermore, the market is also anticipated to be driven by the rising technological developments in single-cell analysis products in the forecasted timeline.

The rising prevalence of cancer globally is anticipated to propel the market growth to a certain extent in the forecasted timeline. One of the biggest causes of death globally is cancer. In the past couple of decades, the condition has undergone substantial growth and is projected to increase exponentially over the forecast timeframe. In 2018, approximately 1,735,350 new cancer cases were identified in the U. S., as per the National Institutes of Health (NIH), and 609,640 individuals died from the disease. Circulatory tumor cells are gaining growing therapeutic attention because they are essential to induce cancer development to be tracked and care modified. In these situations, single-cell sequencing has been used to pursue improved diagnostic and prognostic genetic markers.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/3716

The increasing biopharmaceutical and biotechnology industries and the rising technological developments in single-cell analysis products are driving the demand for the market – Our Expert Review

 

Further key findings from the report suggest:

  • The cancer segment is expected to dominate the market with a CAGR of 17.4% in the forecasted timeline. Single-cell research effectively addresses the data resolution problems, and a detailed description of tumor development, metastasis, immune evasion, and antibiotic resistance has been produced. These variables have contributed to the considerable adoption of this technology in molecular genetics, leading to this segment’s anticipated prominence.
  •  
  • The flow cytometry segment is anticipated to be gradually growing over the expected timeframe. The segment’s growth is due to the commonly used flow cytometry in the identification and calculation of cell or particle occupants’ physical and chemical characteristics.
  •  
  • The Asia Pacific is anticipated to experience the fastest growth in the Single Cell Analysis market, owing to growing biotechnology funding by suppliers and clients. The Single Cell Analysis market in the region is also spurred by increasing demand for biopharmaceuticals and rising R&D activities in the biopharmaceutical industry.

 

Competitive Landscape:

The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The Single Cell Analysis market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.

Leading companies operating in the market are:

General Electric Company, Fluidigm Corporation, NanoString Technologies, Inc., Fluxion Biosciences Inc, Luminex Corporation, Tecan Group Ltd., Promega Corporation, Becton, Dickinson and Company, Silicon Biosystems Menarini, Inc., Illumina, Inc., among others.

The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:

Single Cell Analysis Market Segmentation:

Product Outlook (Revenue, USD Billion; 2017-2027)

  • Instruments
  • Consumables

 

Type Outlook (Revenue, USD Billion; 2017-2027)

  • Animal
  • Human
  • Microbial

 

Technique Outlook (Revenue, USD Billion; 2017-2027)

  • Microscopy
  • Flow Cytometry
  • Polymerase Chain Reaction
  • Mass Spectrometry
  • Next-Generation Sequencing
  • Others

 

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Stem cell
  • Cancer
  • Neurology
  • In-vitro fertilization
  • Immunology
  • Non-invasive prenatal diagnosis

 

Geographic Segment Covered in the Report:

The Single Cell Analysis report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (the USA and Canada)

• Europe (UK, Germany, France, and the rest of Europe)

• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)

• Latin America (Brazil, Mexico, and the rest of Latin America)

• the Middle East and Africa (GCC and the rest of the Middle East and Africa)

 

Key market aspects are illuminated in the report:

  • Executive Summary: It covers a summary of the most vital studies, the Global Single Cell Analysis market increasing rate, modest circumstances, market trends, drivers and problems as well as macroscopic pointers.
  •  
  • Study Analysis: Covers major companies, vital market segments, the scope of the products offered in the Global Single Cell Analysis market, the years measured, and the study points.
  •  
  • Company Profile: Each Firm well-defined in this segment is screened based on a products, value, SWOT analysis, their ability and other significant features.
  •  
  • Manufacture by Region: This Global Single Cell Analysis report offers data on imports and exports, sales, production and key companies in all studied regional markets.

 

Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report. 

Explore More Industry Research by Reports and Data:

Real-World Evidence Solutions Market, By Component (Datasets [Claims and Billing Data, Pharmacy Data, Product and Disease Registries Data, Clinical Settings Data, Patient-Powered Data, and Other Datasets], and Consulting and Analytics), By Therapeutic Area, By Application, By End-User, and By Region Forecast to 2030

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/report-detail/single-cell-analysis-market

  Categories:
view more articles

About Article Author